News Releases

TORONTO , March 30, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the three

TORONTO , March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible preferred

TORONTO , March 10, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30 .

Chad A. Zaring, Appointed Chief Commercial Officer TORONTO , March 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A.

CE Mark Approval for Venus Bliss ™️ for Non-Invasive Lipolysis of Abdomen & Flanks, Skin Tightening, Circumferential Reduction and Cellulite Reduction Health Canada License to Market NeoGraft 2.0 for hair restoration TORONTO , Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc.

TORONTO , Jan. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary unaudited revenue results for the three months and twelve months ended December 31, 2019 and introduced